Parkinson’s Disease

Latest News

Abnormal Cerebral Blood Flow May Influence the Etiology of Parkinson Disease

By

Amit Akirov, MD

Patients with Parkinson disease tend to have an increase in iron content with reduced perfusion in the substantia nigra.

Iron Deposition Provides Cognitive Clues in Patients with Parkinson Disease

By

Alyssa Capel

Up to half of patients with Parkinson disease are also diagnosed with dementia, but tools to track changes in cognition are lacking.

Ophthalmologic Symptoms Common in Parkinson Disease

Patients with Parkinson disease have a higher prevalence of ophthalmologic symptoms than controls.

Stress-Related Disorders Linked to Neurodegenerative Disease

Stress-related disorders are associated with an increased risk for neurodegenerative diseases.

Possible Molecular Signature for Young-Onset Parkinson Disease Identified

By

Alyssa Capel

There is a distinct genetic signature for young-onset Parkinson disease even in cells from those who have no known Parkinson disease-related mutations.

Active Lifestyle May Lower Risk for Parkinson Disease

A physically active lifestyle is associated with a reduced risk for Parkinson disease.

No Evidence of Links Between Olfactory Dysfunction and Bipolar Disorder

By

Laurel Ranger

Olfactory dysfunction is a marker for a number of neuropsychiatric disorders, including Parkinson disease, Alzheimer disease, and schizophrenia.

Inappropriate Atypical Antipsychotics Increase Mortality in Parkinson Disease

By

Laurel Ranger

In long-term care facilities, the rate of antipsychotic use in patients with PD ranges from 15% to 30%; however, the efficacy of AAPs in these patients has not been evaluated in large clinical trials.

Outpatient Palliative Care Improves Parkinson Outcomes

Compared with standard care alone, outpatient palliative care is associated with benefits among patients with Parkinson disease and related disorders.

Infinity DBS System Gains Expanded Approval for Parkinson Disease Management

By

Steve Duffy

The FDA has approved an expanded indication for the Infinity™ Deep Brain Stimulation (DBS) system (Abbott) to include targeting the internal globus pallidus, which may lead to symptom improvement in patients with Parkinson disease.